Linking Intellectual Capital and Financial Performance in Pharmaceutical Companies
-
Published:2023-06-03
Issue:1
Volume:24
Page:65-73
-
ISSN:0972-222X
-
Container-title:DELHI BUSINESS REVIEW
-
language:
-
Short-container-title:DBR
Author:
Chauhan Abhay Singh
Publisher
Journal Press India
Reference24 articles.
1. 1. Abhayawansa, S., & Azim, M. (2014). Corporate reporting of intellectual capital: evidence from the Bangladeshi pharmaceutical sector. Asian Review of Accounting, 22(2), 98-127. https://doi.org/10.1108/ARA-10-2013-0067.
2. 2. Acuña-Opazo, C., & Contreras Gonz Alez, O. (n.d.). The impacts of intellectual capital on financial performance and value-added of the production evidence from Chile Standard-Nutzungsbedingungen: The impacts of intellectual capital on financial performance and value- added of the production evidence from Chile. https://doi.org/10.1108/JEFAS-08-2019-0178.
3. 3. Baliga, B. R., Moyer, R., & Rao, R. S. (1996). CEO Duality and Firm Performance: What's the Fuss? Strategic Management Journal. https://doi.org/10.1002/ (SICI)1097-0266(199601)17:1.
4. 4. Bharathi Kamath, G. (2008). Intellectual capital and corporate performance in Indian pharmaceutical industry. Journal of Intellectual Capital, 9(4), 684-704. https://doi.org/10.1108/14691930810913221/FULL/XML
5. 5. Bontis, N., Chua Chong Keow, W., & Richardson, S. (2000). Intellectual capital and business performance in Malaysian industries. Journal of Intellectual Capital, 1(1), 85-100. https://doi.org/10.1108/14691930010324188.